Zheng Quan Shi Bao Wang·2025-10-13 12:28Group 1 - Multiple listed companies, including Chenguang Biological and Shengnuo Biological, expect net profit to double in the first three quarters of 2025 [1] - Chenguang Biological forecasts a net profit of 278 million to 314 million yuan, representing a year-on-year growth of 344.05% to 401.55% [1] - Chenguang Biological attributes its performance improvement to increased revenue and gross profit from plant extraction products and a recovery in cottonseed business [1] Group 2 - Shengnuo Biological anticipates a net profit of 114 million to 140 million yuan, an increase of 100.53% to 145.1% year-on-year [2] - Shengnuo Biological cites stable development in its main business and growing demand for peptide raw materials as key factors for its performance [2] - Sanmei Co. expects a net profit of 1.524 billion to 1.646 billion yuan, with a year-on-year increase of 171.73% to 193.46% due to reduced production quotas and rising downstream demand [2] Group 3 - Yuegui Co. predicts a net profit of 420 million to 470 million yuan, reflecting a year-on-year growth of 86.87% to 109.11% [2] - Yuegui Co. attributes its performance to cost reduction efforts and rising prices of major mineral products [2] - Xichang Electric forecasts a net profit of approximately 12.4 million yuan, a growth of about 150.51% compared to the previous year [3] Group 4 - Xichang Electric's performance is driven by increased sales volume, effective cost management, and favorable water conditions for power generation [3] - Tian'ao Electronics expects a third-quarter net profit of 6.683 million to 7.623 million yuan, a year-on-year increase of 1281.13% to 1475.39% [3] - Tian'ao Electronics indicates that its overall performance for the first nine months of 2025 is expected to decline due to market competition and project progress [3]